Search Results 211-220 of 21294 for hepatitis
To determine the prevalence of MBL in patients with chronic hepatitis C who are to begin therapy with DAA, and compare with clinic controls who are seen in the ...
Tenofovir alafenamide is used to treat chronic hepatitis B virus (HBV) infection in patients with compensated liver disease. This medicine is available only ...
Combination Therapy Of Pegylated Interferon Alfa-2a And Tenofovir Versus Tenofovir Monotherapy In Chronic Hepatitis B ... hepatitis B. The primary measure ...
The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., at Mayo Clinic targets liver cancer genes and works to prevent hepatitis B and C ...
Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...
The purpose of this study is to assess dose-related safety, early efficacy, pharmacokinetics and pharmacodynamics of INT-787 in patients with severe alcohol- ...
For hepatitis C virus infection, in combination with interferon alfa-2b: For oral dosage form (capsules):. Adults—Dose is based on body weight and must be ...
Screen for liver infections, such as hepatitis. Monitor a disease, such as viral or alcoholic hepatitis, and determine how well a treatment is working. Look for ...
Treatment of hepatitis C in cirrhotic patients and liver transplant recipients · Outcome of liver transplantation in patients with viral hepatitis · Treatment and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.